| Dr Frances Smith, OD | |
|
820 N Chelan Ave, Wenatchee, WA 98801-2028 | |
| (509) 663-8711 | |
| Not Available |
| Full Name | Dr Frances Smith |
|---|---|
| Gender | Female |
| Speciality | Optometry |
| Experience | 12 Years |
| Location | 820 N Chelan Ave, Wenatchee, Washington |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1356605695 | NPI | - | NPPES |
| P01648982 | Other | WA | RR PTAN WVH |
| 1356605695 | Medicaid | WA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | 3449ATI (Oregon) | Secondary |
| 152W00000X | Optometrist | OD60291678 (Washington) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Central Washington Hospital | Wenatchee, WA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Central Washington Health Services Association | 4880504596 | 645 |
News Archive
"During my visit to the Médecins Sans Frontières [MSF] Buruli ulcer ward in Cameroon it was wonderful to see the amazing care that the patients receive on a daily basis: antibiotics, state of the art dressings, physiotherapy to help prevent deformities, free food and medicines, and surgery when required," Daniel O'Brien, a specialist adviser with MSF-UK focusing on HIV/AIDS, tuberculosis and Buruli ulcer, writes in the BMJ Group Blogs.
Ipsen today announced that the phase III clinical trial evaluating Decapeptyl (triptorelin pamoate) 11.25 mg administered subcutaneously in patients with locally advanced or metastatic prostate cancer has met its primary endpoints.
Genes and cardiovascular health each contribute in an additive way to a person's risk of dementia, U.S. researchers including Sudha Seshadri, MD, and Claudia Satizabal, PhD, of The University of Texas Health Science Center at San Antonio (UT Health San Antonio) reported July 20 in the journal Neurology.
The Tuttlingen medical technology company Aesculap AG has founded the Freiburg startup neuroloop GmbH in cooperation with the University of Freiburg and the Freiburg University Medical Center. Building on research work from a team led by Prof. Dr. Thomas Stieglitz at the university's Department of Microsystems Engineering (IMTEK) and a research group at the university medical center, the company plans to develop neurostimulators that will be capable among other things of lowering high blood pressure.
Addressing government entitlement programs, including Medicare, are key to that effort. Meanwhile, GOP presidential hopeful Newt Gingrich offers his own plans for wringing savings from health care costs.
› Verified 2 days ago
| Provider Name | Central Washington Health Services Association |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1801937453 PECOS PAC ID: 4880504596 Enrollment ID: O20031106000287 |
News Archive
"During my visit to the Médecins Sans Frontières [MSF] Buruli ulcer ward in Cameroon it was wonderful to see the amazing care that the patients receive on a daily basis: antibiotics, state of the art dressings, physiotherapy to help prevent deformities, free food and medicines, and surgery when required," Daniel O'Brien, a specialist adviser with MSF-UK focusing on HIV/AIDS, tuberculosis and Buruli ulcer, writes in the BMJ Group Blogs.
Ipsen today announced that the phase III clinical trial evaluating Decapeptyl (triptorelin pamoate) 11.25 mg administered subcutaneously in patients with locally advanced or metastatic prostate cancer has met its primary endpoints.
Genes and cardiovascular health each contribute in an additive way to a person's risk of dementia, U.S. researchers including Sudha Seshadri, MD, and Claudia Satizabal, PhD, of The University of Texas Health Science Center at San Antonio (UT Health San Antonio) reported July 20 in the journal Neurology.
The Tuttlingen medical technology company Aesculap AG has founded the Freiburg startup neuroloop GmbH in cooperation with the University of Freiburg and the Freiburg University Medical Center. Building on research work from a team led by Prof. Dr. Thomas Stieglitz at the university's Department of Microsystems Engineering (IMTEK) and a research group at the university medical center, the company plans to develop neurostimulators that will be capable among other things of lowering high blood pressure.
Addressing government entitlement programs, including Medicare, are key to that effort. Meanwhile, GOP presidential hopeful Newt Gingrich offers his own plans for wringing savings from health care costs.
› Verified 2 days ago
| Provider Name | Wenatchee Valley Hospital |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1669719688 PECOS PAC ID: 9537309869 Enrollment ID: O20130716000034 |
News Archive
"During my visit to the Médecins Sans Frontières [MSF] Buruli ulcer ward in Cameroon it was wonderful to see the amazing care that the patients receive on a daily basis: antibiotics, state of the art dressings, physiotherapy to help prevent deformities, free food and medicines, and surgery when required," Daniel O'Brien, a specialist adviser with MSF-UK focusing on HIV/AIDS, tuberculosis and Buruli ulcer, writes in the BMJ Group Blogs.
Ipsen today announced that the phase III clinical trial evaluating Decapeptyl (triptorelin pamoate) 11.25 mg administered subcutaneously in patients with locally advanced or metastatic prostate cancer has met its primary endpoints.
Genes and cardiovascular health each contribute in an additive way to a person's risk of dementia, U.S. researchers including Sudha Seshadri, MD, and Claudia Satizabal, PhD, of The University of Texas Health Science Center at San Antonio (UT Health San Antonio) reported July 20 in the journal Neurology.
The Tuttlingen medical technology company Aesculap AG has founded the Freiburg startup neuroloop GmbH in cooperation with the University of Freiburg and the Freiburg University Medical Center. Building on research work from a team led by Prof. Dr. Thomas Stieglitz at the university's Department of Microsystems Engineering (IMTEK) and a research group at the university medical center, the company plans to develop neurostimulators that will be capable among other things of lowering high blood pressure.
Addressing government entitlement programs, including Medicare, are key to that effort. Meanwhile, GOP presidential hopeful Newt Gingrich offers his own plans for wringing savings from health care costs.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Frances Smith, OD 820 N Chelan Ave, Wenatchee, WA 98801-2028 Ph: (509) 663-8711 | Dr Frances Smith, OD 820 N Chelan Ave, Wenatchee, WA 98801-2028 Ph: (509) 663-8711 |
News Archive
"During my visit to the Médecins Sans Frontières [MSF] Buruli ulcer ward in Cameroon it was wonderful to see the amazing care that the patients receive on a daily basis: antibiotics, state of the art dressings, physiotherapy to help prevent deformities, free food and medicines, and surgery when required," Daniel O'Brien, a specialist adviser with MSF-UK focusing on HIV/AIDS, tuberculosis and Buruli ulcer, writes in the BMJ Group Blogs.
Ipsen today announced that the phase III clinical trial evaluating Decapeptyl (triptorelin pamoate) 11.25 mg administered subcutaneously in patients with locally advanced or metastatic prostate cancer has met its primary endpoints.
Genes and cardiovascular health each contribute in an additive way to a person's risk of dementia, U.S. researchers including Sudha Seshadri, MD, and Claudia Satizabal, PhD, of The University of Texas Health Science Center at San Antonio (UT Health San Antonio) reported July 20 in the journal Neurology.
The Tuttlingen medical technology company Aesculap AG has founded the Freiburg startup neuroloop GmbH in cooperation with the University of Freiburg and the Freiburg University Medical Center. Building on research work from a team led by Prof. Dr. Thomas Stieglitz at the university's Department of Microsystems Engineering (IMTEK) and a research group at the university medical center, the company plans to develop neurostimulators that will be capable among other things of lowering high blood pressure.
Addressing government entitlement programs, including Medicare, are key to that effort. Meanwhile, GOP presidential hopeful Newt Gingrich offers his own plans for wringing savings from health care costs.
› Verified 2 days ago
Vision Source Of Wenatchee, Ps Optometrist Medicare: Medicare Enrolled Practice Location: 1190 5th St, Wenatchee, WA 98801 Phone: 509-662-9671 Fax: 509-662-9672 | |
Nicholas Allen Donaghey, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 1190 5th St, Wenatchee, WA 98801 Phone: 509-662-9671 Fax: 509-662-9672 | |
Nikita Katoozi, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 1190 5th St, Wenatchee, WA 98801 Phone: 509-662-9671 Fax: 509-662-9672 | |
Aleice Jane Vujnovich Ellerkamp, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 820 N Chelan Ave, Wenatchee, WA 98801 Phone: 509-663-8711 | |
Dr. Allison D Zimmer, O.D. Optometrist Medicare: Medicare Enrolled Practice Location: 1340 N Wenatchee Ave, Wenatchee, WA 98801 Phone: 509-663-8868 Fax: 509-663-9006 | |
Dr. Jesse Quinton Mccarrell, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 820 N Chelan Ave, Wenatchee, WA 98801 Phone: 509-663-8711 | |
Dr. Jason D Barnes, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 1190 5th St, Wenatchee, WA 98801 Phone: 509-662-9671 |